Efficacy of a Computerized Cognitive Behavioral Treatment for Insomnia: Increasing Access to Insomnia Treatment to Decrease Suicide Risk

Insomnia Clinical Trial

— Vets Sleep  

Official title:

Efficacy of a Computerized Cognitive Behavioral Treatment for Insomnia: Increasing Access to Insomnia Treatment to Decrease Suicide Risk

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03366870
• Other study ID #: 17-0920
• Status: Completed
• Phase: N/A
• Start date: March 24, 2018
• Est. completion date: June 16, 2020

Study information

• Verified date: June 2020
• Source: University of Colorado, Denver
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Insomnia is major problem among Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) Veterans. Insomnia impacts physical and mental health functioning and is associated with reduced quality of life. Cognitive Behavioral Therapy for Insomnia (CBT-I) is one of the most promising treatments for insomnia; however, access to CBT-I is severely limited by a lack of trained clinicians within the Veterans Health Administration (VHA) and Department of Defense (DoD). There is a critical need to offer innovative approaches to meet the demand and need for insomnia treatment. Leveraging technology to meet treatment demands is consistent with service delivery models based upon stepped care principles. This randomized controlled trial will determine whether a computerized, self-guided, web-based version of CBT-I is efficacious in reducing insomnia symptoms and improving functioning compared to a computerized program control.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 250
• Est. completion date: June 16, 2020
• Est. primary completion date: June 16, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

1. Age between 18 and 55

2. History of deployment in the Global War on Terror

3. Eligible to receive care through VA ECHCS

4. Reliable access to the Internet

5. English speaking

6. Able to provide informed consent

7. Current insomnia diagnosis as defined by Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5) criteria

Exclusion Criteria:

1. Currently enrolled in/participating in other intervention research studies

2. Other untreated sleep disorders (e.g., sleep apnea, periodic limb movement)

3. Currently receiving formal psychological treatment for insomnia (not including sleep medications)

4. Past 3 month change in schedule and/or dosage of medications that are designed to improve/impact sleep

5. History of Bipolar Disorder (with manic episodes), Schizophrenia, Schizoaffective Disorder, or a Psychotic Disorder

6. Untreated seizures or seizure disorder

7. Physical illness that is active, unstable, degenerative, and/or progressive

8. Currently pregnant or plan to become pregnant in the next 6 months

9. Irregular work schedule, shift work, and/or life changes (e.g., new baby) interfering with regular sleep patterns

10. Significant cognitive impairment, as determined by chart review and/or during screening, that would interfere with ability to engage in SHUTi

11. Current non-alcohol Substance Use Disorder, excluding Cannabis Use Disorder, as determined by chart review and/or self-report screen of drug use (> 1 time) in past 3 months

12. Current Alcohol Use Diagnosis, as determined by SCID 5 module, in the past 3 months

Related Conditions & MeSH terms

• Insomnia
• Mental Health Functioning
• Physical Health Functioning
• Sleep Initiation and Maintenance Disorders
• Suicide

Intervention

Behavioral:
• Computerized Cognitive Behavioral Therapy for Insomnia
A computerized insomnia intervention that employs the same behavioral, educational, and cognitive treatment components that underlie non-computerized CBT-I.
• Sleep Education
A web-based program will deliver components of sleep education via an Internet platform.

Locations

Country	Name	City	State
United States	Rocky Mountain Regional VA Medical Center	Aurora	Colorado

Sponsors (3)

Lead Sponsor	Collaborator
University of Colorado, Denver	Denver Research Institute, Military Suicide Research Consortium

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Insomnia Symptom Severity as Measured by the Insomnia Severity Index	The primary analyses will be the intent-to-treat comparison between groups of the change in insomnia symptom severity as measured by the ISI from Time 1 to Time 2. Statistical inference regarding the difference between intervention groups will be based on the estimated coefficient for a group indicator variable in each of three analysis of covariance models with the change from Time 1 to Time 2 for each outcome serving as the dependent variable. Additional covariates will include the baseline value of the outcome to improve precision of the estimate, and any potential confounders discovered in the randomization check.	Baseline and 9 Weeks
Primary	Maintenance of Change in Insomnia Symptom Severity as Measured by the Insomnia Severity Index at 6-months and 1-Year Post-Intervention	A similar analysis will be performed for the above noted insomnia severity outcome on the change from Time 1 to Time 3 and to Time 4 to determine persistence of group differences to six-months and one-year post-intervention.	Baseline, 6-Months and 1-Year
Secondary	Change in Physical Health and Mental Health Functioning as Measured by the Veteran's SF-36	A similar analysis will be performed with physical health and mental health functioning as the outcomes, based on self-reported responses to the Veteran's SF-36 measure.	Baseline and 9 Weeks
Secondary	Maintenance of Change in Physical Health and Mental Health Functioning as Measured by the Veteran's SF-36 at 6-months and 1-Year Post-Intervention	A similar analysis will be performed for the above noted outcomes on the change from Time 1 to Time 3 and to Time 4 to determine persistence of group differences to six-months and one-year post-intervention.	Baseline, 6-Months and 1-Year